Clinical Trials Browser

Phase 2 × Rectal Neoplasms × (225)Ac-DOTA-c(RGDyK) × Clear all

NCT05308446 2026-06-03

Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation

Phase 2 Active not recruiting

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms